IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-β in NK cells via the c-Jun N-terminal kinase (JNK) pathway

Cellular Immunology

Volumn 242, Issue 1, 2006, Pages 39-45

  Song, Hyunkeun ^a   Hur, Dae Young ^a   Kim, Kyung Eun ^b   Park, Hyunjeong ^c   Kim, Taesung ^d   Kim, Chul woo ^e   Bang, Saic ^f   Cho, Dae Ho ^b  

^a Inje University   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Korea University   (South Korea)

^e Seoul National University   (South Korea)

^f Sungkyunkwan University   (South Korea)

Author keywords

IL 18; IL 2; NK cells; NKG2D; TGF

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; INTERLEUKIN 18; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR NKG2D; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL; CANCER PATIENT; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-18; INTERLEUKIN-2; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 33845446684     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2006.09.002     Document Type: Article

References (42)

1. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47 (1989) 187-376
2. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9 (1997) 24-34
3. Lanier L.L., Spits H., and Phillips J.H. The developmental relationship between NK cells and T cells. Immunol. Today 13 (1992) 392-395
4. Biron C.A., van den Elsen P., Tutt M.M., Medveczky P., Kumar V., and Terhorst C. Murine natural killer cells stimulated in vivo do not express the T cell receptor alpha, beta, gamma, T3 delta, or T3 epsilon genes. J. Immunol. 139 (1987) 1704-1710
5. Biron C.A., Su H.C., and Orange J.S. Function and regulation of natural killer (NK) cells during viral infections: characterization of responses in vivo. Methods: Companion Methods Enzymol. 9 (1996) 379-393
6. Wang B., Biron C.A., She C.J., Higgins K., Sunshine M.J., Lacy E., Lonberg N., and Terhorst C. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3gene. Proc. Natl. Acad. Sci. USA 91 (1994) 9402-9406
7. Wu J., Song Y., Bakker A., Bauer S., Spies T., Lanier L.L., and Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP 10. Science 285 (1999) 730-732
8. Eleme K., Taner S.B., Onfelt B., Collinson L.M., McCann F.E., Chalupny N.J., Cosman D., Hopkins C., Magee A.I., and Davis D.M. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J. Exp. Med. 199 (2004) 1005-1010
9. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., and Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16, and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 (2001) 123-133
10. Cerwenka A., Baron J.L., and Lanier L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98 (2001) 11521-11526
11. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., and Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727-729
12. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3 (2003) 781-790
13. Vivier E., Tomasello E., and Paul P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?. Curr. Opin. Immunol. 14 (2002) 306-311
14. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., and Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93 (1996) 12445-12450
15. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., and Spies T. Costimulation of CD8 alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2 (2001) 255-260
16. Lee J.C., Lee K.M., Kim D.W., and Heo D.S. Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J. Immunol. 172 (2004) 7335-7340
17. Friese M.A., Wischhusen J., Wick W., Weiler M., Eisele G., Steinle A., and Weller M. RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res. 64 (2004) 7596-7603
18. Dasgupta S., Bhattacharya-Chatterjee M., O'malley B.W., and Chatterjee Jr. S.K. Inhibition of NK cell activity through TGF-{β}1 by down-regulation of NKG2D in a murine model of head and neck cancer. J. Immunol. 175 (2005) 5541-5550
19. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., and Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91
20. Dinarello C.A. Interleukin-18. Methods 19 (1999) 121-132
21. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., and Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70 (1998) 281-312
22. Tsutsui H., Nakanishi K., Matsui K., Higashino K., Okamura H., Miyazawa Y., and Kaneda K. IFN-gamma inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157 (1996) 3967-3973
23. Hashimoto W., Osaki T., Okamura H., Robbins P.D., Kurimoto M., Nagata S., Lotze M.T., and Tahara H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J. Immunol. 163 (1999) 583-589
24. Dao T., Mehal W.Z., and Crispe I.N. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 161 (1998) 2217-2222
25. Micallef M.J., Tanimoto T., Kohno K., Ikeda M., and Kurimoto M. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res. 57 (1997) 4557-4563
26. Son Y.I., Dallal R.M., Mailliard R.B., Egawa S., Jonak Z.L., and Lotze M.T. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Cancer Res. 61 (2001) 884-888
27. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., Perricaudet T., Tursz T., Maraskovsky E., and Zitvogel L. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5 (1999) 405-411
28. + T cells. J. Immunol. 144 (1990) 3980-3986
29. Gong J., Maki G., and Klingemann H.-G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8 (1994) 652-658
30. Tam Y.K., Maki G., Miyagawa B., Hennemann B., Tonn T., and Klingemann H.-G. Characterization of genetically altered, interleukin 2-independent natural killer cell lines sui for adoptive cellular immunotherapy. Hum. Gene Ther. 10 (1999) 1359-1373
31. Pende D., Rivera P., Marcenaro S., Chang C.C., Biassoni R., Conte R., Kubin M., Cosman D., Ferrone S., Moretta L., and Moretta A. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 62 (2002) 6178-6186
32. Strong R.K. Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer. Mol. Immunol. 38 (2002) 1029-1037
33. Sutherland C.L., Chalupny N.J., Schooley K., VandenBos T., Kubin M., and Cosman D. UL16-binding proteins,novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J. Immunol. 168 (2002) 671-679
34. Nishioka Y., Nishimura N., Suzuki Y., and Sone S. Human monocyte-derived and CD83(+) blood dendritic cells enhance NK cell-mediated cytotoxicity. Eur. J. Immunol. 31 (2001) 2633-2641
35. Fernandez N.C., Flament C., Crepineau F., Angevin E., Vivier E., and Zitvogel L. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. Eur. Cytokine Netw. 13 (2002) 17-27
36. Munz C., Dao T., Ferlazzo G., de Cos M.A., Goodman K., and Young K.W. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 105 (2005) 266-273
37. Lindsey K.R., Rosenberg S.A., and Sherry R.M. Impact of the number of treatment courses on the clinical response of patients who receive high-dose bolus interleukin-2. J. Clin. Oncol. 18 (2000) 1954-1959
38. Anderson T.D., Hayes T.J., Gately M.K., Bontempo J.M., Stern L.L., and Truitt G.A. Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes: separation of efficacy and toxicity by selective lymphocyte subset depletion. Lab. Invest. 59 (1988) 598-612
39. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
40. Chuang S.S., Lee J.K., and Mathew P.A. Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells. Immunology 109 (2003) 432-439
41. Huntington N.D., Xu Y., Nutt S.L., and Tarlinton D.M. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells. J. Exp. Med. 201 (2005) 421-433
42. Vaidya S.V., and Mathew P.A. An Ets element regulates the transcription of the human 2B4 gene in natural killer cells. Biochim. Biophys. Acta 1728 (2005) 181-185